Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Global Medical REIT (GMRE-PA) over the last 12 years, with Q3 2025 value amounting to $11.2 million.

  • Global Medical REIT's Depreciation & Amortization (CF) rose 1220.85% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 639.02%. This contributed to the annual value of $40.4 million for FY2024, which is 203.32% down from last year.
  • As of Q3 2025, Global Medical REIT's Depreciation & Amortization (CF) stood at $11.2 million, which was up 1220.85% from $11.3 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Depreciation & Amortization (CF) registered a high of $11.3 million during Q2 2025, and its lowest value of $7.8 million during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $10.1 million (2024), whereas its average is $9.9 million.
  • As far as peak fluctuations go, Global Medical REIT's Depreciation & Amortization (CF) soared by 3447.57% in 2021, and later tumbled by 363.06% in 2024.
  • Global Medical REIT's Depreciation & Amortization (CF) (Quarter) stood at $9.0 million in 2021, then rose by 16.96% to $10.6 million in 2022, then decreased by 3.55% to $10.2 million in 2023, then dropped by 0.1% to $10.2 million in 2024, then increased by 10.0% to $11.2 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $11.2 million for Q3 2025, versus $11.3 million for Q2 2025 and $10.3 million for Q1 2025.